CNS Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 5
- Market Cap
- -
- Website
- http://www.cnspharma.com
- Introduction
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Housto...
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- CNS Pharmaceuticals, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT04762069
- Locations
- 🇺🇸
Baylor Research Institute, Dallas, Texas, United States
🇺🇸Southern California Permanente Medical Group, Los Angeles, California, United States
🇺🇸Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath